Condition: High-normal Blood Pressure · Sponsor: Indena S.p.A
The purpose of this study is to evaluate whether a standardized grape seed extract, compared to placebo, can significantly influence systolic blood pressure (SBP) in individuals with high-normal blood pressure (BP) who are adhering to a low-sodium Mediterranean diet. Additionally, the effects of the grape seed extract on diastolic blood pressure (DBP), other hemodynamic parameters, and the Perceived Stress Score will be assessed.
This description comes directly from the study's public registry record.
Giovanna Petrangolini, BD · +39 02 57496493 · giovanna.petrangolini@indena.com
Always discuss trial participation with your own doctor first.
| Cardiovascular Internal Medicine Unit, IRCCS University Hospital of Bologna, Bologna, Italy | Bologna, Bo, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07090876